Hæmatologiske bivirkninger I de kliniske studier med MabThera monoterapi forekom hæmatologiske bivirkninger hos en minoritet af patienterne og var sædvanligvis lette og reversible.
Haematologic Adverse Reactions In clinical trials with MabThera monotherapy given for 4 weeks, haematological abnormalities occurred in a minority of patients and were usually mild and reversible.